Ticker brief
MNPR
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
7
authors 14d
6
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-21 → 2026-06-30 · now +0.34 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @kkernttb | C | +1.42 | 2 | +0.42 |
| @Brad_E_Schulz | C | · | 1 | +0.10 |
| @BioStocks | C | -0.39 | 1 | +0.40 |
| @Quantumup1 | C | -1.95 | 1 | +0.45 |
| @BiopharmIQ | B | · | 1 | +0.00 |
| @PrismMarketView | C | · | 1 | +0.50 |
Recent signals7of 7 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-30 | @PrismMarketView | +0.50 | FDA granted rare pediatric disease designation for MNPR treatment. | · | tweet ↗ |
| 2026-06-30 | @BiopharmIQ | +0.00 | Biotech open news list with percentage moves and headlines. | · | tweet ↗ |
| 2026-06-30 | @Quantumup1 | +0.45 | BTIG raises MNPR PT to $117 from $104 and reiterates Buy on regulatory outlook. | · | tweet ↗ |
| 2026-06-30 | @BioStocks | +0.40 | MNPR received FDA Rare Pediatric Disease Designation for ALXN1840. | · | tweet ↗ |
| 2026-06-23 | @kkernttb | +0.50 | MNPR had a nice breakout today. | · | tweet ↗ |
| 2026-06-23 | @Brad_E_Schulz | +0.10 | Intraday category performance table with percentage moves and breadth. | · | tweet ↗ |
| 2026-06-21 | @kkernttb | +0.35 | Lists best setups from a watchlist with more than six tickers. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.